Controlling Citrate Synthase Expression by CRISPR/Cas9 Genome Editing for n-Butanol Production in Escherichia coli
- Authors
- Heo, Min-Ji; Jung, Hwi-Min; Um, Jaeyong; Lee, Sang-Woo; Oh, Min-Kyu
- Issue Date
- Feb-2017
- Publisher
- AMER CHEMICAL SOC
- Keywords
- Escherichia coli; CRISPR/Cas9; genome editing; 5 '-untranslated region; n-butanol
- Citation
- ACS SYNTHETIC BIOLOGY, v.6, no.2, pp 182 - 189
- Pages
- 8
- Indexed
- SCIE
SCOPUS
- Journal Title
- ACS SYNTHETIC BIOLOGY
- Volume
- 6
- Number
- 2
- Start Page
- 182
- End Page
- 189
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/29484
- DOI
- 10.1021/acssynbio.6b00134
- ISSN
- 2161-5063
- Abstract
- Genome editing using CRISPR/Cas9 was successfully demonstrated in Esherichia coli to effectively produce n-butanol in a defined medium under microaerobic condition. The butanol synthetic pathway genes including those encoding oxygen-tolerant alcohol dehydrogenase were overexpressed in metabolically engineered E. coli, resulting in 0.82 g/L butanol production. To increase butanol production, carbon flux from acetyl-CoA to citric acid cycle should be redirected to acetoacetyl-CoA. For this purpose, the 5'-untranslated region sequence of gltA encoding citrate synthase was designed using an expression prediction program, UTR designer, and modified using the CRISPR/Cas9 genome editing method to reduce its expression level. E. coli strains with decreased citrate synthase expression produced more butanol and the citrate synthase activity was correlated with butanol production. These results demonstrate that redistributing carbon flux using genome editing is an efficient engineering tool for metabolite overproduction.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.